Leaky Gut
Of the 4 unique stories with a clear outcome, 4 reported it helped (100%).
These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.
“my bloating went down and my food intolerance improved significantly”
“I've seen that people have really good responses to oral BPC with that or even glutin tolerance”
“GI patients are tapering off their acid blockers after having their symptoms resolved”
“I take BPC 157 and my digestive system recovers fast”
Related research
Duodenocolic fistula healing by pentadecapeptide BPC 157 in rats. A cytoprotection viewpoint.
The study found that BPC-157, a stable gastric pentadecapeptide, rapidly induces vessel recruitment and healing in rats with duodenocolic fistulas, leading to closed defects and resolved leakage. All BPC-157-treated rats showed significant improvement, with no fistula leakage, diarrhea, or weight loss, and reduced adhesion formation and intestinal obstruction.
Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats.
BPC-157 therapy was shown to heal established vesicovaginal fistulas and counteract stone formation in rats, with significant improvements in epithelization, collagenization, and granulation tissue. The therapy was effective even when initiated with a considerable delay after fistula formation.
Stable gastric pentadecapeptide BPC 157 heals rat colovesical fistula.
BPC-157, a stable gastric pentadecapeptide, was shown to rapidly improve and eventually heal colovesical fistulas in rats. The treatment led to the amelioration of colon and vesical defects, reduction of fistula leakage, and prevention of adhesion formation and intestinal obstruction.
Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.
This review summarizes the evidence for the cytoprotective effects of BPC-157, a stable gastric pentadecapeptide, in resolving major vessel occlusion disturbances and ischemia-reperfusion injury. The review concludes that BPC-157 has profound cytoprotective activity and may be useful in various therapeutic applications.